x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Relapse Tumors, N = 13)	Pediatric Relapse Tumors	13	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		10.62	4.76	3.34	8.02	11.36	12.4	19.43
Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Relapse Tumors, N = 5)	Pediatric Relapse Tumors	5	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	PBTA	Neuroblastoma		EFO_0000621	MONDO_0005072		7.21	3.76	3.34	4.03	6.94	9.35	12.4
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Relapse Tumors, N = 8)	Pediatric Relapse Tumors	8	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		12.76	4.15	8.02	10.54	11.94	14.48	19.43
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 13)	TCGA Relapse Tumors	13	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		4.94	2.97	0.99	3.9	4.34	4.9	12.09
Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 14)	TCGA Relapse Tumors	14	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	TCGA	Low-grade glioma		MONDO_0021637	MONDO_0021637		4.14	1.5	1.41	3.3	3.98	4.79	7.19
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 5)	TCGA Relapse Tumors	5	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		4.23	1.72	1.63	3.39	4.89	5.41	5.84
Sarcoma  (Dataset = TCGA, Specimen = TCGA Relapse Tumors, N = 3)	TCGA Relapse Tumors	3	ENSG00000157764	BRAF	Relevant Molecular Target (PMTL version 3.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		4.45	1.65	2.79	3.63	4.48	5.28	6.08
